RM
RP Management Portfolio holdings
AUM
$139M
This Quarter Return
-30.95%
1 Year Return
-37.98%
3 Year Return
+207.23%
5 Year Return
+1,005.94%
10 Year Return
–
AUM
$283M
AUM Growth
+$283M
(-26%)
Cap. Flow
+$38.8M
Cap. Flow
% of AUM
13.68%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
EPZM
Epizyme, Inc
EPZM
|
$38.8M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 79.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EPZM
1
DELISTED
Epizyme, Inc
EPZM
| $142M | 44.14% |
9,166,667
+2,500,000
| +37% | +$38.8M |
|
|
BHVN
2
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $71.8M | 22.3% |
2,111,111
| – | – |
|
|
IMMU
3
DELISTED
Immunomedics Inc
IMMU
| $59M | 18.3% |
4,373,178
| – | – |
|
4
Cytokinetics
CYTK
$4.23B
| $10.3M | 3.21% |
875,656
| – | – |
|
|
VIRX
5
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $53K | 0.02% |
129,517
| – | – |
|